Physician profile
Suzanne H Calhoun
NPI 1508884693
$2,479.50
in general payments reported to CMS, 2019-2025
15 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $79.82 · 2021: $129 · 2022: $386 · 2023: $264 · 2024: $572 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $355.45 | 2019-2025 | Invega Sustenna, Spravato |
| Alkermes, INC. | $348.17 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Abbvie INC. | $331.96 | 2021-2025 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $243.27 | 2019-2025 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $242.78 | 2019-2025 | Rexulti, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $190.08 | 2019-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.71 | 2020-2025 | Caplyta |
| Axsome Therapeutics, INC. | $132.39 | 2023-2025 | Auvelity |
| Lundbeck LLC | $107.61 | 2019-2025 | Abilify Asimtufii |
| Sunovion Pharmaceuticals INC. | $105.06 | 2019 | |
| Indivior INC. | $102.94 | 2022-2025 | Perseris, Sublocade |
| Vanda Pharmaceuticals INC. | $67.30 | 2019-2025 | Fanapt |
| Allergan, INC. | $59.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $31.89 | 2025 | Cobenfy |
| Braeburn INC. | $21.89 | 2024 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Calhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.